User:Ozzie10aaaa/medical editing archive: Difference between revisions
Ozzie10aaaa (talk | contribs) |
Ozzie10aaaa (talk | contribs) |
||
Line 54: | Line 54: | ||
*{{cite book |last1=Division |first1=Health and Medicine |last2=Health |first2=Board on Global |last3=Threats |first3=Forum on Microbial |title=The Ebola Epidemic in West Africa: Proceedings of a Workshop |date=2016 |publisher=National Academies Press |isbn=9780309450065 |url=https://books.google.com/books?id=aYCPDgAAQBAJ&printsec=frontcover&dq=ebola+congo&hl=en&ppis=_c&sa=X&ved=2ahUKEwiRiMytpffkAhVDPawKHQyBDDwQ6AEwBXoECAEQAg#v=onepage&q=ebola%20congo&f=false |accessdate=30 September 2019 |language=en}} |
*{{cite book |last1=Division |first1=Health and Medicine |last2=Health |first2=Board on Global |last3=Threats |first3=Forum on Microbial |title=The Ebola Epidemic in West Africa: Proceedings of a Workshop |date=2016 |publisher=National Academies Press |isbn=9780309450065 |url=https://books.google.com/books?id=aYCPDgAAQBAJ&printsec=frontcover&dq=ebola+congo&hl=en&ppis=_c&sa=X&ved=2ahUKEwiRiMytpffkAhVDPawKHQyBDDwQ6AEwBXoECAEQAg#v=onepage&q=ebola%20congo&f=false |accessdate=30 September 2019 |language=en}} |
||
*{{cite journal |last1=Ousman |first1=Kevin |last2=Kabego |first2=Landry |last3=Talisuna |first3=Ambrose |last4=Diaz |first4=Janet |last5=Mbuyi |first5=John |last6=Houndjo |first6=Bienvenu |last7=Ngandu |first7=Jean-Paul |last8=Omba |first8=Gaston |last9=Aruna |first9=Aaron |last10=Mossoko |first10=Mathias |last11=Djingarey |first11=Mamadou Harouna |last12=Balde |first12=Thierno |last13=Abok |first13=Patrick |last14=Diallo |first14=Boubacar |last15=Dovlo |first15=Delanyo |last16=Yao |first16=Michel |last17=Fortin |first17=Anne |last18=Formenty |first18=Pierre |last19=Fall |first19=Ibrahima Soce |title=The impact of Infection Prevention and control (IPC) bundle implementationon IPC compliance during the Ebola virus outbreak in Mbandaka/Democratic Republic of the Congo: a before and after design |journal=BMJ open |date=5 September 2019 |volume=9 |issue=9 |pages=e029717 |doi=10.1136/bmjopen-2019-029717 |url=https://www.ncbi.nlm.nih.gov/pubmed/31492782 |accessdate=30 September 2019 |issn=2044-6055}} |
*{{cite journal |last1=Ousman |first1=Kevin |last2=Kabego |first2=Landry |last3=Talisuna |first3=Ambrose |last4=Diaz |first4=Janet |last5=Mbuyi |first5=John |last6=Houndjo |first6=Bienvenu |last7=Ngandu |first7=Jean-Paul |last8=Omba |first8=Gaston |last9=Aruna |first9=Aaron |last10=Mossoko |first10=Mathias |last11=Djingarey |first11=Mamadou Harouna |last12=Balde |first12=Thierno |last13=Abok |first13=Patrick |last14=Diallo |first14=Boubacar |last15=Dovlo |first15=Delanyo |last16=Yao |first16=Michel |last17=Fortin |first17=Anne |last18=Formenty |first18=Pierre |last19=Fall |first19=Ibrahima Soce |title=The impact of Infection Prevention and control (IPC) bundle implementationon IPC compliance during the Ebola virus outbreak in Mbandaka/Democratic Republic of the Congo: a before and after design |journal=BMJ open |date=5 September 2019 |volume=9 |issue=9 |pages=e029717 |doi=10.1136/bmjopen-2019-029717 |url=https://www.ncbi.nlm.nih.gov/pubmed/31492782 |accessdate=30 September 2019 |issn=2044-6055}} |
||
*{{cite web |title=Genomic epidemiology of the 2018-19 Ebola epidemic |url=https://nextstrain.org/community/inrb-drc/ebola-nord-kivu |website=nextstrain.org |accessdate=9 November 2019}} |
|||
<small>{{Note2}}due to the increase in cases 250/140 death<sup>approx.</sup> per [https://mailchi.mp/sante.gouv.cd/ebola_kivu_16oct?e=2bde1f126a MOH] & [https://www.aljazeera.com/news/2018/10/ebola-spread-uganda-rwanda-warns-181011141950957.html WHO warns:] infobox, page move graph,table might need to be changed.</small> |
<small>{{Note2}}due to the increase in cases 250/140 death<sup>approx.</sup> per [https://mailchi.mp/sante.gouv.cd/ebola_kivu_16oct?e=2bde1f126a MOH] & [https://www.aljazeera.com/news/2018/10/ebola-spread-uganda-rwanda-warns-181011141950957.html WHO warns:] infobox, page move graph,table might need to be changed.</small> |
||
Revision as of 14:15, 9 November 2019
Extended content
|
---|
- prepare
- Ga
- dyk
- will publish Sent
Extended content
|
---|
- prepare
- will GAreverse
- will dyk
- will publish Sent
Extended content
|
---|
- prepare
- GA
- dyk
- will publish Sent
Extended content
|
---|
Epidemiology(other factors)This particular outbreak started on August 1, just a few days after the prior 9th outbreak[2].Some factors that are different from the 2018 Équateur province Democratic Republic of the Congo Ebola virus outbreak are the following:
If the EVD lingers long enough due to military conflict and the high number of zones(area) affected,[9] Uganda and the millions of entering refugees could become a major problem[10]Currently there are 160 cases and almost 100 deaths, as of 23 September in DRC[11]Peter Salama of the World Health Organization on 25 September, indicated that insecurity is obstructing efforts to stop the virus and believes a combination of factors could establish conditions for an epidemic[12] On 24 November, it was reported that the current EVD outbreak would become the second biggest ever in history.[13] Uganda would eventually declare 4 cases, all died of EVD.[14] TanzaniaThe WHO stated on 21 September that "to date, the clinical details and the results of the investigation, including laboratory tests performed for differential diagnosis of these patients, have not been shared with WHO. The insufficient information received by WHO does not allow for a formulation of a hypotheses regarding the possible cause of the illness".[15][16][17] On 27 September, the CDC and U.S. State Department alerted potential travellers to the possibility of unreported EVD cases within Tanzania,[18] one day later the United Kingdom began indicating to potential travelers to Tanzania, the undiagnosed death of an individual and the WHO, 21 September statement on the issue.[19] TreatmentMonitored Emergency Use of Unregistered Interventions has been used by the World Health Organization in this outbreak.WHO indicated that favipiravir is the most uncertain in terms of benefits/risks[20] As a recent article indicates transparency is very important[21]; in the use of treatment options in this outbreak 35 individuals have been treated, 16 were discharged, 11 are still in the hospital and 8 died.[22]On 12 August, for the first time, two clinical trial medications were found to improve the rate of survival in those infected by EVD. They are REGN-EB3, a cocktail of three monoclonal Ebola antibodies, and mAb114. These two will be further used in therapy, ZMapp has been discontinued.[23][24][25][26] ref
pubmed/other search
Note:due to the increase in cases 250/140 deathapprox. per MOH & WHO warns: infobox, page move graph,table might need to be changed. |
- - - see above
*NPR medical article† *(in the future)may place copy peer reviews WikiJournal of Medicine here ‡